BC Cancer researchers part of international collaboration to develop treatments for osteosarcoma
BC Cancer researchers are playing a central role in a new international collaboration aimed at developing innovative treatments for osteosarcoma — a highly malignant bone cancer that commonly affects children and adolescents.
Careers
How to Apply
Applicants interested in pursuing graduate or postdoctoral training in The Department of Molecular Oncology, please e-mail us directly at careersmolonc@bccrc.ca. Please include the following documents when applying:
- Cover Letter
- CV
- Statement of your research interests and experience
- Transcripts
- Contact information for two or three references
Outstanding Trainee Paper Competition 2020 Winners
Dr. Poul Sorensen awarded Order of British Columbia
Scientists obtain real-time look at how cancers evolve
This year, approximately 4,060 British Columbians will be diagnosed with breast cancer. While many forms of breast cancer can be treated successfully, triple negative breast cancer (TNBC) remains the most deadly subtype because it is resistant to most forms of treatment.
Targeting MondoA: A potential new treatment for childhood leukemia
Scientists had previously noted that the presence of a large protein called MondoA was associated with worse outcomes in several pediatric cancers, but they didn’t understand why.
UBC and BC Cancer researchers develop new test to better diagnose different types of ovarian cancer
The new test will be able to better diagnose different types of ovarian cancer, a tool that could one day guide and improve treatment options for patients.
BC Cancer and UBC researchers have identified how hormones and aging affect breast cancer in largest study of its kind
After reviewing over 7,000 cancer tissues, the correlation between hormones and aging to developing breast cancer is now better understood.
Dr. Poul Sorensen awarded the 2020 Aubrey J. Tingle Prize
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.